Skip to main content
Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
68.14
+0.77 (1.14%)
At close: Mar 9, 2026, 4:00 PM EDT
68.25
+0.11 (0.16%)
After-hours: Mar 9, 2026, 7:51 PM EDT

Halozyme Therapeutics Employees

Halozyme Therapeutics had 423 employees as of December 31, 2025. The number of employees increased by 73 or 20.86% compared to the previous year.

Employees
423
Change (1Y)
73
Growth (1Y)
20.86%
Revenue / Employee
$3,301,681
Profits / Employee
$749,147
Market Cap
8.04B

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 20254237320.86%
Dec 31, 2024350-23-6.17%
Dec 31, 2023373-20-5.09%
Dec 31, 2022393248171.03%
Dec 31, 202114596.62%
Dec 31, 202013643.03%
Dec 31, 2019132-149-53.02%
Dec 31, 20182812610.20%
Dec 31, 2017255-4-1.54%
Dec 31, 20162594319.91%
Dec 31, 20152166341.18%
Dec 31, 2014153-17-10.00%
Dec 31, 20131701811.84%
Dec 31, 20121521712.59%
Dec 31, 20111353332.35%
Dec 31, 2010102-38-27.14%
Dec 31, 2009140107.69%
Dec 31, 20081303841.30%
Dec 31, 20079252130.00%
Dec 31, 200640--
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.

Related Stocks

Company Name Employees
Bio-Techne 3,100
Axsome Therapeutics 925
Arrowhead Pharmaceuticals 711
ImmunityBio 691
Cytokinetics 673
Vaxcyte 507
Krystal Biotech 295
Nuvalent 228
Employee Rankings

HALO News

More News